Search 

Business Sweden helps global companies to establish business and research activities in Sweden. We provide advice, information and support free of charge and in full confidentiality. Our industry experts can connect you with the right business and investment opportunities, being the best partner when investing in Sweden.

DiagnoChrome is a spin-off company of the Biotechnology Center at the Universidad de Concepcion, Chile. La company develops kits for the diagnostics of plant pathogens, being our first kit the detection of Botrytis cinerea in bluberries. 

The Center for Biotechnology and Bioengineering is created in 2014, after being selected by the Research Partnership Program of CONICYT to be part of the national program for Basal Funding for Excellence Scientific and Technological Centers.

CeBiB is a Centre of Excellence in cutting-edge research composed by an interdisciplinarian team of renowned national and international scientits, capable of investigating key aspects and current trens in biotechnology and bioengineering, including the research for important applications for industry.

One of the main goals of CeBiB is the research and development of applications to be used in areas where Chile has significant comparative advantages, looking for these areas always in line with the interests of the industry and the needs of the public and private sectors, to increase the competitiveness of the national economy based on scientific and technological innovation.

CeBiB is composed by researchers and academics leaders in their fields from Chilean universities: Universidad de Chile, Universidad de Antofagasta, Universidad de Santiago de Chile, Universidad de La Frontera and Universidad de Los Lagos.

Korea Trade Investment Promotion Agency, otherwise known as KOTRA, operates under South Korea's Ministry of Trade, Industry & Energy (MOTIE), as the national trade and investment promotion organization.  KOTRA is a governmental, non-profit agency which promotes and facilitates bilateral business relationships between Korea and the world since its foundation in 1962.

Since inception, KOTRA has facilitated Korea's rapid, export-led economic development through various trade promotion activities such as SME export promotion, trade info services, government-to-government export, foreign investment in Korea (FDI) promotion, and business matchmaking. KOTRA maintains over 120 offices in 82 countries with 13 in South Korea alone. 

I am currently co-leading North America's Startup GP program. A collaboration project between KOTRA's Global Partnering and Overseas Startup Assistance Program. This effort is a part of Korean President Park Geun-hye's "Creative Economy" policy designed to help promising Korean startups connect with leading Corporate Venture Capital firms in the US for potential partnership and investment opportunities.

Lastly, I am the Head of Medical GP. Connect US based Medical and Pharmaceutical companies with Korean counterparts and implement R&D projects, which are co-funded by the Korean government, and I.P. licensing. 

The Massachusetts Life Sciences Center (MLSC) is an investment agency that supports life sciences innovation, research, development and commercialization. The MLSC is charged with implementing a $1-billion, state-funded investment initiative. These investments create jobs and support advances that improve health and well-being. The MLSC offers the nation’s most comprehensive set of incentives and collaborative programs targeted to the life sciences ecosystem. These programs propel the growth that has made Massachusetts the global leader in life sciences. The MLSC creates new models for collaboration and partners with organizations, both public and private, around the world to promote innovation in the life sciences.

OBIO, a not-for-profit, membership-based organization engaged in the development of and integrated health innovation economy for Ontario that will become a leader in providing health technology to the internatoinal marketplace. A key initiative is the OBIO Capital Access Advisory Programs (CAAP).  Led by OBIO and a North American Steering Committee including senior venture capitalists and seasoned entrepreneurs from MedImmune Ventures, Johns Hopkins, J&J, Genesys Capital, Lumira Capital, BDC Capital and Versant Ventures, we work with high-potential CAAP companies including those devloping therapeutics, med device, diagnostics and HIT products and services.